In July, AmeriHealth updated several policies. Published updates include:
- 08.00.85m: Tocilizumab (Actemra®) for Intravenous Infusion. Effective date: July 18, 2022
- 08.01.94: Nivolumab and relatlimab-rmbw (Opdualag™). Effective date: July 18, 2022
To view the latest medical and claim payment policy bulletins, visit the Medical and Claim Payment Policy Portal.
For important policy information related to COVID-19, visit the News & Announcements section of the portal.